AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / LABORATORY ANALYTICAL INSTRUMENTS
Bio-Rad Laboratories, Inc.Class A
XNYS · usd
SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS
FIGI BBG001S625W4
369.95▲ 6.45 (1.77%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
363.50
Day's Range
352.46 – 371.31
52-Week Range
236.73 – 396.23
Volume
167.4K
Avg Volume
256.8K
Share Statistics
Shares Outstanding
Employees
7,450
Exchange
XNYS
Listed
1980-02-29
Share count as of July 30, 2026

Bio-Rad Laboratories, Inc.Class A (BIO) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Bio-Rad Laboratories, Inc.Class A (BIO)
What is Bio-Rad Laboratories, Inc.Class A's Market Cap?
Bio-Rad Laboratories, Inc.Class A's Market Cap is $9.9B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Enterprise Value?
Bio-Rad Laboratories, Inc.Class A's Enterprise Value is $9.1B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Trailing P/E?
Bio-Rad Laboratories, Inc.Class A's Trailing P/E is 44.5×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Price / Sales?
Bio-Rad Laboratories, Inc.Class A's Price / Sales is 3.8×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's EV / Revenue?
Bio-Rad Laboratories, Inc.Class A's EV / Revenue is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's EV / EBITDA?
Bio-Rad Laboratories, Inc.Class A's EV / EBITDA is 41.4×, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Revenue (TTM)?
Bio-Rad Laboratories, Inc.Class A's Revenue (TTM) is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Net Income (TTM)?
Bio-Rad Laboratories, Inc.Class A's Net Income (TTM) is $222.4M, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's EBITDA?
Bio-Rad Laboratories, Inc.Class A's EBITDA is $218.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bio-Rad Laboratories, Inc.Class A's Diluted EPS (TTM)?
Bio-Rad Laboratories, Inc.Class A's Diluted EPS (TTM) is 8.32, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BIOAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth-0.1%+1.1%+3.9%+0.5%
Cost of goods sold
Gross profit
% of revenue53.1%52.3%49.8%52.6%
Selling, general and administrative expense
Research and Development Expense
Segment profit (loss)
% of revenue11.2%5.8%-17.2%10.0%
Interest expense
Foreign exchange (gains) losses, net
Marketable Securities, Unrealized (Gain) Loss—
Other Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
(Provision) benefit for income taxes
Net income attributable to Bio-Rad
% of revenue57.1%-89.0%103.9%-52.4%
Net income per share basic attributable to Bio-Rad
Net income per share diluted attributable to Bio-Rad